ZeClinics - Biotechnology CRO - Powering Discovery with Zebrafish ZeClinics - Biotechnology CRO - Powering Discovery with Zebrafish ZeClinics - Biotechnology CRO - Powering Discovery with Zebrafish
  • About us
    • About us overview
    • Our History
    • Our Mission
    • Our Model
    • Our Environment
    • Our Partners
    • Our Careers
  • Services & Solutions

    BY OUR PLATFORMS

    • ZeTox
    • Fast Acute Toxicity
    • DevTox
    • CardioTox
    • NeuroTox
    • HepatoTox
    • OtoTox
    • ZeGlobalTox
    • Endocrine Disruption Assay
    • ReproductionTox
    • Early-life stage toxicity
    • ADME - Bioavailability
    • ZeGenesis
    • CRISPR/Cas9 Knock-out
    • Generation of Stable knock-out lines
    • Somatic knock-out (Crispants)
    • Morpholino-based knock-down
    • Tol2 Transgenic lines
    • Cardiophenotyping
    • Neurophenotyping
    • Customized phenotyping
    • ZeEfficacy
    • Epilepsy Model
    • Parkinson Disease Model
    • Hearing Loss Model
    • Retinal Degeneration Model
    • Duchenne Muscular Dystrophy(DMD) Model
    • Atherosclerosis Model

    BY THERAPEUTIC AREA

    • Otolaryngology
    • Ophthalmology
    • Oncology
    • Metabolic
    • Muscular
    • CNS

    BY RESEARCH STAGE

    • Model Generation
    • Target ID & validation
    • Screening
    • Hit confirmation
    • Hit-to-Lead
    • Tox - ADME
  • Blog
  • Media
  • Contact
> Blog

Blog

All ZeClinics News Events Posters Papers
ZECLINICS NEWS

27 May 2014

Zebrafish Make a Splash in FDA Research

ZECLINICS NEWS

09 May 2014

Zebrafish in FENS FORUM 2014: The power of stripes

ZECLINICS NEWS

30 April 2014

ZeClinics and the embryonic development of the hindbrain

ZECLINICS NEWS

24 March 2014

ZeClinics presents you ZeGENESIS

Javier Terriente, our CSO, in El•lipse nº72 ZECLINICS NEWS

13 March 2014

Javier Terriente, our CSO, in El•lipse nº72

ZECLINICS NEWS

30 January 2014

ZeClinics will give a talk at Neuroscience Institute of Alicante

ZECLINICS NEWS

14 November 2013

ZeClinics is attending…

Drug Developed Based On Zebrafish Studies Passes Phase I Clinical Trial ZECLINICS NEWS

08 November 2013

Drug Developed Based On Zebrafish Studies Passes Phase I Clinical Trial

ZECLINICS NEWS

21 October 2013

ZeClinics is attending the PharmaProcess Forum

ZECLINICS NEWS

14 October 2013

ZeClinics joins…

« Previous 1 … 13 14 15

Read the poster

Please leave your details in the form below.


    * Mandatory field


    * Mandatory field

    DATA PROTECTION INFORMATION
    Data controller ZeClinics SL
    Purpose To attend your requests of information and/or suggestions
    Legal basis Consent of the data subject
    Recipients None, unless to comply with legal obligations
    Rights To access, rectify and erase personal data, as well as other rights as detailed in the additional information section
    Additional information For additional information on how ZeClinics processes your personal data please click here.

    * Mandatory field
    Captcha erróneo

    ABOUT US Our History Our Mission Our Model Our Environment Our Partners Our Careers
    SERVICES & SOLUTIONS BY OUR PLATFORMS ZeTox ZeGenesis ZeEfficacy
    BY THERAPEUTIC AREA BY RESEARCH STAGE
    BLOG ZeClinics News Posters Papers Events
    MEDIA
    CONTACT Contact-us Office Address Laboratory Address
    Privacy policy Terms of Use Cookies

    © 2020 ZeClinics

    Designed by Auupa

    • Twitter
    • Linkedin
    • Youtube

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it, but you can opt-out if you wish.

    Accept Decline Cookie Settings
    I consent to the use of following cookies:
    Cookie Declaration About Cookies
    Necessary (1) Marketing (1) Analytics (1) Preferences (0) Unclassified (0)
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
    Name Domain Purpose Expiry Type
    wpl_user_preference zeclinics.com User preference control 12 months HTTP
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
    Name Domain Purpose Expiry Type
    Youtube youtube.com Play youtube embed videos 12 months HTTP
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
    Name Domain Purpose Expiry Type
    Google Analytics zeclinics.com Analytics Cookie 12 months HTTP
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
    We do not use cookies of this type.
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
    We do not use cookies of this type.
    Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.